Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Attune Pharmaceuticals presents promising data for ATN-249 in hereditary angioedema

Jan. 25, 2019

Bioverativ begins phase I/II study of BIVV-003 in sickle cell disease

Jan. 14, 2019

Protagonist Therapeutics initiates phase II study of PTG-300 in patients with beta-thalassemia

Jan. 11, 2019

Common mechanism links diverse anemias

Jan. 11, 2019

Results presented from phase III CASSINI study evaluating rivaroxaban thromboprophylaxis

Jan. 3, 2019

Sustained clinical benefit in patients with beta-thalassemia following LentiGlobin gene therapy

Dec. 28, 2018

Small studies, in the aggregate, yield "robust data" on thrombosis

Dec. 28, 2018

Alnylam Pharmaceuticals develops siRNA targeting the thrombopoietin gene in the liver

Dec. 27, 2018

Researchers present new gene therapy for sickle cell anemia

Dec. 27, 2018

Hemlibra subcutaneous injection approved in Japan for hemophilia A without inhibitors

Dec. 24, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...